You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Brain Metastases, CNS Metastases

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Melanoma, Brain Metastases Trial in Tucson (E6201, E6201 plus dabrafenib)

Terminated
Has Results
  • Malignant Melanoma
  • Brain Metastases
  • Tucson, Arizona
    University of Arizona Cancer Center
Mar 5, 2022

Breast Cancer, Brain Metastases, HER2-positive Breast Cancer Trial in Los Angeles (Tucatinib, Pembrolizumab, Trastuzumab)

Withdrawn
  • Breast Cancer
  • +3 more
  • Los Angeles, California
    Cedars-Sinai Medical Center
Jun 28, 2022

Advanced Cancer, Brain Metastases Trial in New Orleans (DM-CHOC-PEN)

Completed
  • Advanced Cancer
  • Brain Metastases
  • New Orleans, Louisiana
    Tulane University Medical Center
Nov 3, 2022

Metastatic Cancer, Brain Metastases Trial in Camden (Stereotactic Radiosurgery)

Withdrawn
  • Metastatic Cancer
  • Brain Metastases
  • Stereotactic Radiosurgery
  • Camden, New Jersey
    MD Anderson Cancer Center at Cooper
Dec 21, 2021

Breast Cancer, Brain Metastases Trial (Neratinib)

Withdrawn
  • Breast Cancer
  • Brain Metastases
  • (no location specified)
Feb 28, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the CNS

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Scottsdale, Arizona
  • +2 more
Jan 4, 2023

Brain Metastases, CNS Tumor, CNS Disorder, Intracranial Trial in Australia, United States (Stereotactic radiosurgery)

Recruiting
  • Brain Metastases
  • +2 more
  • Stereotactic radiosurgery
  • Birmingham, Alabama
  • +4 more
Jul 13, 2022

Lung Cancer, NSCLC, Brain Metastases Trial (Alectinib, Stereotactic Radiosurgery)

Not yet recruiting
  • Lung Cancer
  • +2 more
  • (no location specified)
Aug 4, 2023

Non Small Cell Lung Cancer Metastatic, Brain Metastases, Adult, KRAS G12C Trial (JDQ443)

Not yet recruiting
  • Non Small Cell Lung Cancer Metastatic
  • +2 more
  • (no location specified)
Aug 11, 2023

Breast Cancer, Brain Metastases, Radiotherapy Trial in Shanghai (Combination use of SRT with T-DXd)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Combination use of SRT with T-DXd
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 14, 2023

Breast Cancer With Brain Metastases Trial in Wuhan (pyrotinib+capecitabine+bevacizumab)

Recruiting
  • Breast Cancer With Brain Metastases
  • Wuhan, Hubei, China
    Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
Nov 22, 2023

NSCLC, EGFR Gene Mutation, Brain Metastases Trial in Worldwide (AZD3759, Erlotinib, Gefitinib)

Completed
  • Non-small Cell Lung Cancer
  • +2 more
  • Hefei, Anhui, China
  • +57 more
Nov 18, 2022

Breast Cancer, Metastatic Breast Cancer Trial (Trastuzumab-Deruxtecan (T-DXd))

Not yet recruiting
  • Breast Cancer
  • Metastatic Breast Cancer
  • Trastuzumab-Deruxtecan (T-DXd)
  • (no location specified)
Sep 20, 2023

Brain Metastases: Value ofLongitudinal Multimodal Approach

Recruiting
  • Brain Metastases, Adult
    • Brest, France
      Chu Brest
    Sep 6, 2023

    Glioblastoma (GBM) Trial in Basel (Advanced diffusion-weighted MRI (ADW-MRI))

    Recruiting
    • Glioblastoma (GBM)
    • Advanced diffusion-weighted MRI (ADW-MRI)
    • Basel, Switzerland
      University Hospital Basel
    Jun 21, 2023

    Radiotherapy, Brain Metastases, Sensitivity Trial in Lund (Brain metastases radiation)

    Recruiting
    • Radiotherapy
    • +3 more
    • Brain metastases radiation
    • Lund, Sweden
      Lund University Hospital
    Jan 5, 2021

    Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain, Stage IV Lung Cancer AJCC v8 Trial in Duarte

    Not yet recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +2 more
    • Biospecimen Collection
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    May 1, 2023

    Metastatic Breast Cancer Trial in Zhengzhou (SHR-A1811, Pyrotinib, Bevacizumab)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    Mar 13, 2023

    Cancer, Metastasis, Metastatic Cancer Trial in Miami (Azeliragon, Stereotactic radiosurgery, Corticosteroid)

    Not yet recruiting
    • Cancer
    • +4 more
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc.
    Mar 16, 2023

    Brain Metastases, Radiotherapy Trial in Heidelberg (Preoperative Radiotherapy, Intraoperative Radiation, Postoperative

    Not yet recruiting
    • Brain Metastases
    • Radiotherapy
    • Preoperative Radiotherapy
    • +2 more
    • Heidelberg, Germany
      Department of Radiotherapy, University of Heidelberg
    May 12, 2023

    NSCLC, Brain Tumors Trial (bevacizumab, First-Line Chemotherapy Agents, Second-Line Chemotherapy Agents)

    Completed
    Has Results
    • Non-Small Cell Lung Cancer
    • Brain Neoplasms
    • (no location specified)
    Dec 9, 2022

    Brain Metastases Trial in Little Rock (SRS/SRT)

    Recruiting
    • Brain Metastases
    • SRS/SRT
    • Little Rock, Arkansas
      University of Arkansas for Medical Sciences
    Jun 8, 2022

    Mammary Tumors, Human Trial in Tianjin (eutidrone etoposide bevacizumab)

    Recruiting
    • Mammary Neoplasms, Human
    • eutidrone etoposide bevacizumab
    • Tianjin, Tianjin, China
      Yehui Shi
    Mar 10, 2023

    Metastatic HER2 Negative Breast Carcinoma, Brain Metastases, Capecitabine Trial in Changsha (UTD1 combined with capecitabine)

    Recruiting
    • Metastatic HER2 Negative Breast Carcinoma
    • +3 more
    • UTD1 combined with capecitabine
    • Changsha, China
      Quchang Ouyang
    Sep 9, 2022

    Brain Metastases, HER2-positive Breast Cancer Trial (Combined use of SRS with Tucatinib, Trastuzumab, and Capecitabine)

    Not yet recruiting
    • Brain Metastases
    • HER2-positive Breast Cancer
    • Combined use of SRS with Tucatinib, Trastuzumab, and Capecitabine
    • (no location specified)
    Jan 10, 2023